FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912204773> ?p ?o ?g. }

• W2912204773 endingPage "363" @default.
• W2912204773 startingPage "355" @default.
• W2912204773 abstract "Recombinant human bone morphogenetic protein 2 (rhBMP-2) has been introduced to clinical practice because of its osteoinductive capacity. However, the evidence of its efficacy in vertical bone augmentation procedures is not clear.The purpose of this systematic review and meta-analysis was to investigate the efficacy of rhBMP-2 in vertical bone augmentation and to establish whether its addition in preclinical experiments (animal studies) would be sufficient to justify further clinical and histometric studies.An electronic search of 3 databases, PubMed/MEDLINE, EMBASE, and Web of Science, and a manual search of the reference list of relevant studies were performed. Only randomized controlled trials regarding animal studies comparing the efficacy of bone grafts supplemented with and without rhBMP-2 in vertical bone augmentation procedures were included and reviewed.Nine studies were included. The results of the meta-analysis showed that the pooled weighted mean difference (WMD) of the percentage of newly formed bone was 9.97% (95% confidence interval [CI]=-0.79% to 20.72%; P=.070), the WMD of the percentage of residual materials was -21.31% (95% CI=-70.62% to 28.00%; P=.400), the WMD of the augmented bone height was 1.70 mm (95% CI=-0.23 to 3.63 mm; P=.080), the WMD of the augmented bone height for studies with space-providing barriers was 1.00 mm (95% CI=0.43 to 1.57 mm; P<.001), and the WMD of the percentage of regenerated tissue was 17.07% (95% CI=8.52% to 25.62%; P<.001).The application of rhBMP-2 in bone substitutes did not enhance new bone formation and residual graft resorption in vertical bone augmentation procedures. Tissue regeneration and the augmented bone height were significantly improved by the additional use of BMP-2." @default.
• W2912204773 created "2019-02-21" @default.
• W2912204773 creator A5002035881 @default.
• W2912204773 creator A5016927477 @default.
• W2912204773 creator A5031458721 @default.
• W2912204773 creator A5036421899 @default.
• W2912204773 creator A5050281661 @default.
• W2912204773 date "2019-10-01" @default.
• W2912204773 modified "2023-09-23" @default.
• W2912204773 title "Preclinical application of recombinant human bone morphogenetic protein 2 on bone substitutes for vertical bone augmentation: A systematic review and meta-analysis" @default.
• W2912204773 cites W1852943991 @default.
• W2912204773 cites W1965732250 @default.
• W2912204773 cites W1968822620 @default.
• W2912204773 cites W1971507509 @default.
• W2912204773 cites W1981131629 @default.
• W2912204773 cites W1993652436 @default.
• W2912204773 cites W1996343426 @default.
• W2912204773 cites W1999538067 @default.
• W2912204773 cites W2010737673 @default.
• W2912204773 cites W2013463731 @default.
• W2912204773 cites W2018602999 @default.
• W2912204773 cites W2022557971 @default.
• W2912204773 cites W2023509149 @default.
• W2912204773 cites W2030050153 @default.
• W2912204773 cites W2031911556 @default.
• W2912204773 cites W2042262230 @default.
• W2912204773 cites W2055032123 @default.
• W2912204773 cites W2056813178 @default.
• W2912204773 cites W2058571677 @default.
• W2912204773 cites W2062312427 @default.
• W2912204773 cites W2068956931 @default.
• W2912204773 cites W2069333999 @default.
• W2912204773 cites W2070863307 @default.
• W2912204773 cites W2070869177 @default.
• W2912204773 cites W2079268771 @default.
• W2912204773 cites W2089813431 @default.
• W2912204773 cites W2098923148 @default.
• W2912204773 cites W2115327066 @default.
• W2912204773 cites W2117934509 @default.
• W2912204773 cites W2121551386 @default.
• W2912204773 cites W2140345517 @default.
• W2912204773 cites W2140523757 @default.
• W2912204773 cites W2143861067 @default.
• W2912204773 cites W2166825694 @default.
• W2912204773 cites W2167094856 @default.
• W2912204773 cites W2176138279 @default.
• W2912204773 cites W2261324366 @default.
• W2912204773 cites W2267078032 @default.
• W2912204773 cites W2396889227 @default.
• W2912204773 cites W2576440140 @default.
• W2912204773 cites W2619089986 @default.
• W2912204773 cites W2622001506 @default.
• W2912204773 cites W2811127580 @default.
• W2912204773 doi "https://doi.org/10.1016/j.prosdent.2018.09.008" @default.
• W2912204773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30782462" @default.
• W2912204773 hasPublicationYear "2019" @default.
• W2912204773 type Work @default.
• W2912204773 sameAs 2912204773 @default.
• W2912204773 citedByCount "6" @default.
• W2912204773 countsByYear W29122047732020 @default.
• W2912204773 countsByYear W29122047732021 @default.
• W2912204773 countsByYear W29122047732022 @default.
• W2912204773 countsByYear W29122047732023 @default.
• W2912204773 crossrefType "journal-article" @default.
• W2912204773 hasAuthorship W2912204773A5002035881 @default.
• W2912204773 hasAuthorship W2912204773A5016927477 @default.
• W2912204773 hasAuthorship W2912204773A5031458721 @default.
• W2912204773 hasAuthorship W2912204773A5036421899 @default.
• W2912204773 hasAuthorship W2912204773A5050281661 @default.
• W2912204773 hasConcept C104317684 @default.
• W2912204773 hasConcept C126322002 @default.
• W2912204773 hasConcept C141071460 @default.
• W2912204773 hasConcept C168563851 @default.
• W2912204773 hasConcept C199343813 @default.
• W2912204773 hasConcept C202751555 @default.
• W2912204773 hasConcept C2993373878 @default.
• W2912204773 hasConcept C3018263421 @default.
• W2912204773 hasConcept C31507581 @default.
• W2912204773 hasConcept C44249647 @default.
• W2912204773 hasConcept C535046627 @default.
• W2912204773 hasConcept C55493867 @default.
• W2912204773 hasConcept C71924100 @default.
• W2912204773 hasConcept C86803240 @default.
• W2912204773 hasConcept C95190672 @default.
• W2912204773 hasConceptScore W2912204773C104317684 @default.
• W2912204773 hasConceptScore W2912204773C126322002 @default.
• W2912204773 hasConceptScore W2912204773C141071460 @default.
• W2912204773 hasConceptScore W2912204773C168563851 @default.
• W2912204773 hasConceptScore W2912204773C199343813 @default.
• W2912204773 hasConceptScore W2912204773C202751555 @default.
• W2912204773 hasConceptScore W2912204773C2993373878 @default.
• W2912204773 hasConceptScore W2912204773C3018263421 @default.
• W2912204773 hasConceptScore W2912204773C31507581 @default.
• W2912204773 hasConceptScore W2912204773C44249647 @default.
• W2912204773 hasConceptScore W2912204773C535046627 @default.
• W2912204773 hasConceptScore W2912204773C55493867 @default.
• W2912204773 hasConceptScore W2912204773C71924100 @default.
• W2912204773 hasConceptScore W2912204773C86803240 @default.

• next